Want to join the conversation?
$AMGN & Euronext Brussels announced STRUCTURE trial results that met the primary endpoint exhibiting substantial difference in favor of romosozumab in the percent change of total hip bone mineral density through month 12. Subject incidence of adverse events was mostly balanced between arms. Further analysis of Phase 3 STRUCTURE study are ongoing.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.